The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice

Gut Pathogens

Volumn 6, Issue 1, 2014, Pages

  Heimesaat, Markus M ^a   Fischer, André ^a   Alutis, Marie ^a   Grundmann, Ursula ^a   Boehm, Manja ^b   Tegtmeyer, Nicole ^b   Göbel, Ulf B ^a   Kühl, Anja A ^a   Bereswill, Stefan ^a   Backert, Steffen ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Cell invasion; Conventional infant mice; Extra intestinal immune responses; Hepatic; Host pathogen interaction; Innate immunity; Pulmonal histopathology; Renal; Ulcerative enterocolitis

Indexed keywords

EID: 84902003368     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-6-16     Document Type: Article

References (57)

1. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. Friedman CR, Neimann J, Wegener HC, Tauxe RV, Campylobacter Washington, DC: ASM Press, Nachamkin I, Blaser MJ, 2000 121 138
2. Campylobacter jejuni: molecular biology and pathogenesis. Young KT, Davis LM, Dirita VJ, Nature Rev Microbiol 2007 5 665 679 10.1038/nrmicro1718 (Pubitemid 47278861)
3. Campylobacter jejuni. Kist M, Bereswill S, Contrib Microbiol 2001 8 150 165 11764732
4. Campylobacter colitis: histological immunohistochemical and ultrastructural findings. van Spreeuwel JP, Duursma GC, Meijer CJ, Bax R, Rosekrans PC, Lindeman J, Gut 1985 26 945 951 10.1136/gut.26.9.945 4029720 (Pubitemid 15229645)
5. Pathophysiology of Campylobacter enteritis. Walker RI, Caldwell MB, Lee EC, Guerry P, Trust TJ, Ruiz-Palacios GM, Microbiol Rev 1986 50 81 94 3515146 (Pubitemid 16122597)
6. Host-pathogen interactions in Campylobacter infections: the host perspective. Janssen R, Krogfelt KA, Cawthraw SA, van Pelt W, Wagenaar JA, Owen RJ, Clin Microbiol Rev 2008 21 505 518 10.1128/CMR.00055-07 18625685
7. Association between Campylobacter infection and Guillain-Barré syndrome. Allos BM, J Infect Dis 1997 176 Suppl 2 125 S128 9396695
8. Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism? Ó'Cróinín T, Backert S, Front Cell Infect Microbiol 2012 2 25 22919617
9. Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Pei Z, Burucoa C, Grignon B, Baqar S, Huang XZ, Kopecko DJ, Bourgeois AL, Fauchere JL, Blaser MJ, Infect Immun 1998 66 938 943 9488379 (Pubitemid 28101130)
10. The pathogenesis of Campylobacter jejuni-mediated enteritis. Konkel ME, Monteville MR, Rivera-Amill V, Joens LA, Curr Issues Intest Microbiol 2001 2 55 71 11721281 (Pubitemid 33061769)
11. Pathogenesis of Campylobacter. Poly F, Guerry P, Curr Opin Gastroenterol 2008 24 27 31 10.1097/MOG.0b013e3282f1dcb1 18043229 (Pubitemid 350190894)
12. Identification of Campylobacter jejuni genes involved in its interaction with epithelial cells. Novik V, Hofreuter D, Galán JE, Infect Immun 2010 78 3540 3553 10.1128/IAI.00109-10 20515930
13. The cooperative action of bacterial fibronectin-binding proteins and secreted proteins promote maximal Campylobacter jejuni invasion of host cells by stimulating membrane ruffling. Eucker TP, Konkel ME, Cell Microbiol 2012 14 226 238 10.1111/j.1462-5822.2011.01714.x 21999233
14. Role of the small Rho GTPases Rac1 and Cdc42 in host cell invasion of Campylobacter jejuni. Krause-Gruszczynska M, Rohde M, Hartig R, Genth H, Schmidt G, Keo T, Koenig W, Miller WG, Konkel ME, Backert S, Cell Microbiol 2007 9 2431 2444 10.1111/j.1462-5822.2007.00971.x 17521326 (Pubitemid 47365648)
15. The signaling pathway of Campylobacter jejuni-induced Cdc42 activation: Role of fibronectin, integrin beta1, tyrosine kinases and guanine exchange factor Vav2. Krause-Gruszczynska M, Boehm M, Rohde M, Tegtmeyer N, Takahashi S, Buday L, Oyarzabal OA, Backert S, Cell Commun Signal 2011 9 32 10.1186/1478-811X-9-32 22204307
16. Major host factors involved in epithelial cell invasion of Campylobacter jejuni: role of fibronectin, integrin beta1, FAK, Tiam-1, DOCK180 in activating Rho GTPase Rac1. Boehm M, Krause-Gruszczynska M, Rohde M, Tegtmeyer N, Takahashi S, Oyarzabal OA, Backert S, Front Cell Infect Microbiol 2011 1 17 22919583
17. Transmigration route of Campylobacter jejuni across polarized intestinal epithelial cells: paracellular, transcellular or both? Backert S, Boehm M, Wessler S, Tegtmeyer N, Cell Commun Signal 2013 11 72 10.1186/1478-811X-11-72 24079544
18. The HtrA protease of Campylobacter jejuni is required for heat and oxygen tolerance and for optimal interaction with human epithelial cells. Brøndsted L, Andersen MT, Parker M, Jørgensen K, Ingmer H, Appl Environ Microbiol 2007 71 3205 3212 (Pubitemid 40807232)
19. HtrA chaperone activity contributes to host cell binding in Campylobacter jejuni. Bæk KT, Vegge CS, Brøndsted L, Gut Pathog 2011 3 13 10.1186/1757-4749-3-13 21939552
20. Distinct roles of secreted HtrA proteases from Gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin. Hoy B, Geppert T, Boehm M, Reisen F, Plattner P, Gadermaier G, Sewald N, Ferreira F, Briza P, Schneider G, Backert S, Wessler S, J Biol Chem 2012 287 10115 10120 10.1074/jbc.C111.333419 22337879
21. Rapid paracellular transmigration of Campylobacter jejuni across polarized epithelial cells without affecting TER: role of proteolytic-active HtrA cleaving E-cadherin but not fibronectin. Boehm M, Hoy B, Rohde M, Tegtmeyer N, Baek KT, Oyarzabal OA, Brondsted L, Wessler S, Backert S, Gut Pathog 2012 4 3 10.1186/1757-4749-4-3 22534208
22. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. Hoy B, Löwer M, Weydig C, Carra G, Tegtmeyer N, Geppert T, Schröder P, Sewald N, Backert S, Schneider G, Wessler S, EMBO Rep 2010 11 798 804 10.1038/embor.2010.114 20814423
23. Extracellular secretion of protease HtrA from Campylobacter jejuni is highly efficient and independent of its protease activity and flagellum. Boehm M, Haenel I, Hoy B, Brøndsted L, Smith TG, Hoover T, Wessler S, Tegtmeyer N, Europ J Immunol Microbiol 2013 3 163 173 10.1556/EuJMI.3.2013.3.3
24. Novel murine infection models provide deep insights into the "Menage a Trois" of Campylobacter jejuni, microbiota and host innate immunity. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, Dasti JI, Zautner AE, Muñoz M, Loddenkemper C, Gross U, Göbel UB, Heimesaat MM, PLoS ONE 2011 6 20953 10.1371/journal.pone.0020953 21698299
25. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. Haag LM, Fischer A, Otto B, Plickert R, Kühl AA, Göbel UB, Bereswill S, Heimesaat MM, PLoS ONE 2012 7 40761 10.1371/journal.pone.0040761 22808254
26. Colonization of infant mice with flagellar variants of Campylobacter jejuni. Diker KS, Hascelik G, Diker S, Acta Microbiol Hung 1992 39 133 136 1307436
27. Bismuth subsalicylate in the prevention of colonization of infant mice with Campylobacter jejuni. Hänninen ML, Epidemiol Infect 1990 104 397 404 10.1017/S0950268800047415 2347383
28. The mechanism of protection of infant mice from intestinal colonisation with Campylobacter jejuni. Abimiku AG, Dolby JM, J Med Microbiol 1987 23 339 344 10.1099/00222615-23-4-339 3585966 (Pubitemid 17099391)
29. Persistence and spread of Candida albicans after intragastric inoculation of infant mice. Field LH, Pope LM, Cole GT, Guentzel MN, Berry LJ, Infect Immun 1981 31 783 791 7012021 (Pubitemid 11146262)
30. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune response. Haag LM, Fischer A, Otto B, Grundmann U, Kühl AA, Göbel UB, Bereswill S, Heimesaat MM, Eur J Microbiol Immunol 2012 2 2 11 10.1556/EuJMI.2.2012.1.2
31. Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Heimesaat MM, Haag LM, Fischer A, Otto B, Kühl AA, Göbel UB, Bereswill S, Eur J Microbiol Immunol 2013 3 174 182 10.1556/EuJMI.3.2013.3.4
32. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA, J Clin Pathol 1994 47 113 116 10.1136/jcp.47.2.113 8132824 (Pubitemid 24095461)
33. Matrix metalloproteinase levels are elevated in inflammatory bowel diseases. Baugh MD, Perry MJ, Hollander AP, Davies DR, Cross SS, Lobo AJ, Taylor CJ, Evans GS, Gastroenterol 1999 117 814 822 10.1016/S0016-5085(99)70339-2 (Pubitemid 29468223)
34. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation. Salmela MT, MacDonald TT, Black D, Irvine B, Zhuma T, Saarialho-Kere U, Pender SL, Gut 2002 51 540 547 10.1136/gut.51.4.540 12235077
35. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. Muñoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, Loddenkemper C, Krell HW, Libert C, Lund LR, Frey O, Hölscher C, Iwakura Y, Ghilardi N, Ouyang W, Kamradt T, Sabat R, Liesenfeld O, J Exp Med 2009 206 3047 3059 10.1084/jem.20090900 19995958
36. The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. Heimesaat MM, Dunay IR, Fuchs D, Trautmann D, Fischer A, Kühl AA, Loddenkemper C, Siegmund B, Batra A, Bereswill S, Liesenfeld O, Eur J Microbiol Immunol 2011 1 302 310 10.1556/EuJMI.1.2011.4.6
37. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Heuschkel RB, MacDonald TT, Monteleone G, Bajaj-Elliott M, Smith JA, Pender SL, Gut 2000 47 57 62 10.1136/gut.47.1.57 10861265 (Pubitemid 30430412)
38. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S, Gut 2000 47 63 73 10.1136/gut.47.1.63 10861266 (Pubitemid 30430413)
39. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Pigrau C, Bartolome R, Almirante B, Planes AM, Gavalda J, Pahissa A, Clin Infect Dis 1997 25 1414 1420 10.1086/516127 9431389 (Pubitemid 28022682)
40. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Tee W, Mijch A, Clin Infect Dis 1998 26 91 96 10.1086/516263 9455515 (Pubitemid 28068160)
41. Enteric campylobacter: purging its secrets? Crushell E, Harty S, Sharif F, Bourke B, Pediatr Res 2004 55 3 12 10.1203/01.PDR.0000099794.06260.71 14605259 (Pubitemid 38018685)
42. Experimental infection of gnotobiotic mice with Campylobacter jejuni: colonisation of intestine and spread to lymphoid and reticulo-endothelial organs. Fauchère JL, Véron M, Lellouch-Tubiana A, Pfister A, J Med Microbiol 1985 20 215 224 10.1099/00222615-20-2-215 4045991 (Pubitemid 16223026)
43. Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. Heimesaat MM, Fischer A, Siegmund B, Kupz A, Niebergall J, Fuchs D, Jahn HK, Freudenberg M, Loddenkemper C, Batra A, Lehr HA, Liesenfeld O, Blaut M, Göbel UB, Schumann RR, Bereswill S, PLoS ONE 2007 2 662 10.1371/journal.pone.0000662 17653282 (Pubitemid 351308764)
44. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU, Sturm A, J Mol Med 2008 86 1395 1406 10.1007/s00109-007-0290-2 18064431
45. Histological grading and staging of chronic hepatitis. Ishak K, Babtista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Philipps MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H, J Hepatol 1995 22 696 699 10.1016/0168-8278(95)80226-6 7560864
46. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D, Medicine 1978 57 371 410 682942 (Pubitemid 8398526)
47. Limited anti-inflammatory role for interleukin-1 receptor like 1 (ST2) in the host response to murine postinfluenza pneumococcal pneumonia. Blok DC, van der Sluijs KF, Florquin S, de Boer OJ, van 't Veer C, de Vos AF, van der Poll T, PLoS ONE 2013 8 58191 10.1371/journal.pone.0058191 23483993
48. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Heimesaat MM, Nogai A, Bereswill S, Plickert R, Fischer A, Loddenkemper C, Steinhoff U, Tchaptchet S, Thiel E, Freudenberg MA, Göbel UB, Uharek L, Gut 2010 59 1079 1087 10.1136/gut.2009.197434 20639251
49. Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens. Wolk DM, Schneider SK, Wengenack NL, Sloan LM, Rosenblatt JE, J Clin Microbiol 2002 40 3922 3928 10.1128/JCM.40.11.3922-3928.2002 12409353 (Pubitemid 35285769)
50. Helicobacter pylori CagL dependent induction of gastrin expression via a novel αvβ5-integrin-integrin linked kinase signalling complex. Wiedemann T, Hofbaur S, Tegtmeyer N, Huber S, Sewald N, Wessler S, Backert S, Rieder G, Gut 2012 61 986 996 10.1136/gutjnl-2011-300525 22287591
51. c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S, J Clin Invest 2012 122 1553 1566 10.1172/JCI61143 22378042
52. Live Helicobacter pylori in the root canal of endodontic-infected deciduous teeth. Hirsch C, Tegtmeyer N, Rohde M, Rowland M, Oyarzabal OA, Backert S, J Gastroenterol 2012 47 936 940 10.1007/s00535-012-0618-8 22722905
53. Electron microscopic, genetic and protein expression analyses of Helicobacter acinonychis strains from a Bengal tiger. Tegtmeyer N, Rivas Traverso F, Rohde M, Oyarzabal OA, Lehn N, Schneider-Brachert W, Ferrero RL, Fox JG, Berg DE, Backert S, PLoS ONE 2013 8 71220 10.1371/journal.pone.0071220 23940723
54. Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori. Tegtmeyer N, Wittelsberger R, Hartig R, Wessler S, Martinez-Quiles N, Backert S, Cell Host Microbe 2011 9 520 531 10.1016/j.chom.2011.05.007 21669400
55. Molecular methods to investigate adhesion, transmigration, invasion and intracellular survival of the foodborne pathogen Campylobacter jejuni. Backert S, Hofreuter D, J Microbiol Meth 2013 95 8 23
56. An RGD helper sequence in CagL of Helicobacter pylori assists in interactions with integrins and injection of CagA. Conradi J, Tegtmeyer N, Woźna M, Wissbrock M, Michalek C, Gagell C, Cover TL, Frank R, Sewald N, Backert S, Front Cell Infect Microbiol 2012 2 70 22919661
57. The Cag pathogenicity island and interaction between TLR2/NOD2 and NLRP3 regulate IL-1β production in Helicobacter pylori infected dendritic cells. Kim DJ, Park JH, Franchi L, Backert S, Núñez G, Eur J Immunol 2013 43 2650 2658 10.1002/eji.201243281 23818043